New PIGN Gene Duplication Identified in Rare MCAHS1 Syndrome

New PIGN Gene Duplication Identified in Rare MCAHS1 Syndrome

The discovery of a recurring ‘AGGTG’ microhomology sequence at the duplication breakpoints suggests that specific DNA repair mechanisms are responsible for these complex PIGN gene disruptions. This finding represents a significant leap in our understanding of Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 1 (MCAHS1), a devastating autosomal recessive disorder. Cataloged under OMIM number 614080, this condition stems from defects in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which are essential for tethering various proteins to cell surfaces. While the PIGN gene is known to facilitate the addition of phosphoethanolamine to the first mannose in the GPI core, previous research focused almost exclusively on small-scale point mutations like missense or nonsense variants. The identification of a large biallelic intragenic tandem duplication marks a turning point, revealing that structural rearrangements can be just as impactful as single-letter typos in the genetic code.

Clinical Manifestations: The Investigative Approach

The diagnostic journey began with a one-month-old male infant in China who presented with a complex clinical phenotype that strongly suggested a severe metabolic or genetic condition. The infant suffered from early-onset seizures and a profound degree of hypotonia, often described as “floppy baby syndrome,” where muscle tone is significantly reduced. In addition to these neurological symptoms, the child exhibited distinct facial dysmorphism and a suite of multisystemic congenital anomalies that underscored the systemic nature of the underlying pathology. Such severe presentations often leave clinicians searching for answers through standard metabolic screens, but the depth of these symptoms pointed toward a fundamental failure in cellular processes. This case highlights how early intervention and precise observation of neonatal symptoms are critical in identifying rare syndromes that might otherwise be overlooked during initial routine examinations.

Because the patient’s symptoms were so extensive, a collaborative team from the Capital Institute of Pediatrics and the Peking Union Medical College spearheaded a deeper investigation into the infant’s genome. They worked alongside specialists from the Chigene Translational Medical Research Center to provide a comprehensive analysis of the infant’s condition. Traditional testing for single-gene defects often yields negative results when structural variations are involved, leading to long diagnostic odysseys for affected families. In this instance, the medical team recognized that the multisystemic involvement, affecting both the central nervous system and structural development, required a more holistic genomic approach. By focusing on the infant’s unique clinical markers, the researchers aimed to bridge the gap between symptomatic observation and molecular confirmation, setting the stage for the application of advanced genomic tools that go beyond the limitations of exome-focused screening.

Genomic Breakthrough: Advanced Sequencing Results

To navigate the complexity of the infant’s genetic landscape, the research team utilized trio whole-genome sequencing (WGS), a method that analyzes the entire genetic makeup of the patient and both parents. Unlike whole-exome sequencing, which only scans the protein-coding regions, WGS allows for a high-resolution examination of introns and intergenic regions where structural variants often hide. This sophisticated approach revealed a novel biallelic intragenic tandem duplication involving exons 2 through 22 of the PIGN gene. Finding such a large-scale duplication is rare in MCAHS1, as most cases involve smaller, more localized mutations. The precision of WGS was instrumental in identifying the exact boundaries of this duplication, demonstrating that the genetic architecture of the syndrome is far more diverse than previously understood. This level of detail is necessary to understand how massive chunks of genetic information can be misplaced without being detected by older sequencing technologies.

Further investigation confirmed that both nonconsanguineous parents were heterozygous carriers of the identical duplication, meaning they each passed a copy of the rearranged gene to their son. This biallelic state meant the infant lacked a functional version of the PIGN gene, leading to the severe symptoms observed at birth. To ensure these results were not an artifact of the sequencing process, the team performed breakpoint-specific junction PCR and Sanger sequencing to validate the findings. These secondary tests confirmed the presence of the duplication across the family unit and provided a definitive molecular diagnosis. By establishing this clear inheritance pattern, the study not only diagnosed the child but also offered the parents crucial information for future family planning. The use of trio-based analysis remains a gold standard for clarifying the significance of novel structural variants, ensuring that the detected anomalies are indeed causative of the clinical phenotype.

Molecular Mechanisms: Insights and Diagnostic Standards

A defining feature of this study was the meticulous analysis of the genetic breakpoints to understand why this specific duplication occurred. The identification of a 5-bp microhomology sequence, specifically “AGGTG,” suggests that the duplication was driven by a microhomology-mediated rearrangement mechanism. During processes like DNA repair or replication, these short, identical sequences can misalign, causing the DNA polymerase to “jump” or loop back on itself. This results in the erroneous doubling of a large segment of the gene, in this case, spanning twenty exons. Understanding these underlying mechanisms is vital for genomics because it explains how repetitive sequences in our DNA can act as hotspots for structural failures. By pinpointing the AGGTG sequence, the researchers provided a mechanical explanation for the duplication, moving beyond just identifying the error to explaining its origin. This mechanical insight helps researchers predict where other similar mutations might occur in the genome.

This collaborative investigation successfully advanced the molecular understanding of MCAHS1 by pinpointing a previously unknown mutation type. The researchers evaluated the functional impact using quantitative reverse-transcription PCR, which revealed that PIGN mRNA expression was significantly lower in carriers, likely due to cellular degradation of faulty transcripts. This confirmed that the tandem duplication fundamentally impaired the gene’s activity and protein synthesis. The study established that when traditional genetic panels fail, high-resolution structural variant analysis must become the diagnostic priority. These findings offered a clear pathway for more precise molecular diagnostics and genetic counseling, ensuring that future patients with complex rearrangements are accurately identified. By broadening the mutational landscape, the team provided a framework for integrating structural genomic analysis into routine pediatric care, which facilitated a more comprehensive understanding of the architecture underlying congenital syndromes.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later